Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.
Health Canada has approved the use of the Dexcom G7 Continuous Glucose Monitoring System with myLoop, powered by CamAPS FX, making it the only automated insulin delivery (AID) system in Canada approved specifically for use during pregnancy.*
Dexcom CEO Jake Leach says the secret to getting ahead isn't asking for a promotion—it's becoming the person willing to take on what others won't.
SAN DIEGO, November 02, 2026--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today launched A Letter to Diabetes in honor of National Diabetes Awareness Month and World Diabetes Day, creating a platform for people around the world to put into words everything they’ve wanted to say about their diabetes journey, from the heartfelt and humorous to the hopeful and unexpected.
DexCom (NASDAQ:DXCM) reported third-quarter 2026 revenue of $1.34 billion, up 11% from a year earlier on both a reported and organic basis, as U.S. growth, market-share gains and manufacturing improvements supported higher profitability. U.S. revenue rose 14% to $970 million, while international re
These aren’t top AI stocks, but the technology is helping improve their businesses.
Diabetes wearables-maker Dexcom topped third-quarter earnings forecasts Thursday and reported in-line sales. Dexcom stock was little moved.
The stock has done well so far while not yet reflecting the larger growth story.
This is the newest page. Registered accounts read further back.